Breathlessness on exertion is common in people with obesity. Assessments of breathlessness may include sensation (intensity, sensory quality or unpleasantness) and/ or the behavioral/emotional consequences of the sensation (respiratory-related functional impairment, disability or quality of life). This systematic review of primary studies published since 2005 evaluated how has the sensation of breathlessness been assessed in adults with increased adiposity. A total of 41 articles were retained from the systematic search strategy resulting in 20 instruments. The Modified Borg Scale (perceived exertion-intensity), the Medical Research Council (MRC) Scale and Baseline Dyspnea Index (BDI; both assess respiratory-related functional impairment) were, respectively, the most frequently reported instruments. Few instruments had been tested for reliability and validity in people with increased adiposity. Visual Analog Scale, Modified Borg Scale, descriptors of sensory quality, MRC and BDI can be recommended as instruments based on their psychometric properties (reliability (correlations 40.8) and concurrent validity (correlation with severity of airways obstruction and walking distance)). A greater number of instruments were identified that assessed the consequences of the breathlessness rather than breathlessness as a sensation. If sensation drives behavior, comprehensive data on the sensation of breathlessness might assist in understanding the behavioral consequences of interventions.
INTRODUCTION
Breathlessness and distress with breathing (dyspnea) are common symptoms in people with increased adiposity (overweight body mass index (BMI) 25-29.9 kg m À 2 or obese X30 kg m À 2 ).
1,2
Among other musculoskeletal, metabolic and cardiovascular alterations, people who are overweight or obese display a number of respiratory physiological alterations in pulmonary volumes, flows and capacities, respiratory mechanics, gas exchange, control of breathing and respiratory muscle function. 3, 4 These physiological mechanisms underpin the functional increase in the work of breathing resulting in breathlessness. It has been suggested that these respiratory alterations may be more related to the distribution of adiposity (waist circumference or waist to hip ratio) rather than BMI. 5, 6 Increased adiposity not only predicts the presence and severity of chronic breathlessness, but also severity of breathlessness is strongly associated with increased BMI and decreased physical activity. 7 Although breathlessness is usually seen as a comorbid effect of increased adiposity, in other chronic conditions where breathlessness is a feature (chronic obstructive pulmonary disease or heart failure), the uncomfortable or distressing sensation of breathlessness leads to early cessation of exercise and facilitates sedentary behaviors resulting in adverse health outcomes (reduced cardiovascular fitness and muscle strength). 8 During the past century our understanding of the sensation of breathlessness has evolved from a simple model of respiratory center stimulation (neurochemical model), to the recognition that receptors including muscle (tension), joint (position sense and displacement), irritant, vascular and airways receptors can modify ventilation (neuromuscular model; Figure 1 ). In the late 1900s, the contribution of physiological, psychological, cognitive, social and environmental factors to the sensory experience of breathlessness was recognized through the American Thoracic Society's definition of dyspnea. 8 A gated neuromatrix model for dyspnea has emerged during the past decade, which integrates afferent inputs from the receptors and systems within the body as well as cortically mediated processes for memory, associations and attention. 9, 10 Where afferent information exceeds a threshold (gate open by increased input from the periphery or consciously directed attention), the individual consciously appreciates intensity and sensory quality (descriptors) of the sensation of breathlessness. 10 A second gating system is involved in determining whether the sensation is pleasant/unpleasant, presumably through comparison of the current sensation with past experiences/expectation of the degree of breathlessness in similar contexts. Where the sensation is perceived to be unpleasant (that is, dyspnea rather than breathlessness) limbic structures associated with fear or alarm are activated evoking an immediate emotional (fear, anxiety and frustration) and behavioral response (cessation or avoidance of physical activity). 10 In conditions where breathlessness is a common symptom (obesity, obstructive and restrictive respiratory disorders), the disparity between motor output and resultant work of breathing is the most likely mechanism underpinning the conscious awareness of a sensation of breathing discomfort or distress.
In many ways, assessments of breathlessness in chronic conditions reflect the contemporary understanding of the mechanisms giving rise to the symptom ( Figure 1 ). To better understand the etiology, pathogenesis and response to intervention, breathlessness assessments have diversified from measures of the severity of physiological impairment (for example, pulmonary function tests, arterial blood gas analysis, exercise performance) to include assessments of how breathlessness impairs functional activities (for example, the New York Heart Classification, Medical Research Council for Breathlessness Scale), quality of life (for example, Chronic Respiratory questionnaire, St George Respiratory questionnaire) and more recently the sensory domains of breathlessness (for example, Visual Analog Scales (VSA) for intensity or unpleasantness, descriptors of sensory quality).
Although it is widely recognized that breathlessness is common in people with increased adiposity, it is unclear how the sensation of breathlessness or dyspnea as opposed to the mechanics of breathlessness, have been examined in this population. The question for this systematic review was 'How has the sensation of breathlessness been assessed in adults with increased adiposity?' Within this question, the two main aims were as follows Identify instruments that have been used to assess the sensation of breathlessness in people with increased adiposity. compare the reliability and concurrent validity of instruments used to assess the sensation of breathlessness in this population, to determine which instruments could be recommended for assessing the sensation of breathlessness in people with increased adiposity.
MATERIALS AND METHODS
A systematic search of four major databases: CINAHL (EBSCO host), Cochrane library, Medline (OVID) and Scopus, was undertaken during November 2010 to February 2011 (with an updated search undertaken in February 2012 to identify papers meeting the inclusion criteria published during 2011). Search terms and associated Medical subject Heading (MeSH) alternatives included obese (obesity and overweight) combined with breathless (breathlessness and dyspnea). Studies were eligible for inclusion within this review if they included adults (X19 year) reported to be obese and included measures of dyspnea or breathlessness as an outcome within the study. Studies that assessed breathlessness as inclusion criteria for participant entry into the study were excluded. In light of the recent emergence of the multidimensional concept of the sensation of breathlessness, time of publication was limited to between January 2005 and 2012 for two reasons. Our understanding of mechanisms underpinning the sensation of breathlessness has evolved rapidly over the past decade, we therefore were interested to see whether and how these concepts might have been taken up within the clinical/research environment. More contemporary articles are likely to reflect the current clinical practice and research allowing readers of this review to consider and identify newer instruments/tools that align with the current understanding of the sensation of breathlessness. Additional limits were applied for language of publication (English), peer reviewed journal articles (no gray literature), experimental/observational designs (or systematic reviews of the same with and without meta-analysis). An a priori strategy including both the search and inclusion/exclusion criteria was developed and piloted by the research team. The final search strategy was undertaken by the primary author (YG) with the abstracts of the first 50 citations assessed for eligibility by all three investigators to confirm consistency of the application of the inclusion criteria. Full-text versions of articles were retrieved for citations that met the inclusion criteria or where the citations could not be excluded because of ambiguity in the abstract. Pearling of reference lists of all articles included within the review was undertaken to identify any further studies. Full-text articles were reviewed and data were extracted using a data collection form for study design, participant characteristics and instruments used to assess breathlessness/dyspnea (Aim 1).
Traditionally, systematic reviews of intervention efficacy, diagnosis or prognosis include appraisal of the methodological bias within studies to determine the believability of the results. However, the aim of this systemic review was to audit instruments used to assess the symptom or sensation of breathlessness in people with obesity, rather than the efficacy of interventions on this sensation. Therefore, an assessment was undertaken of the psychometric properties (reliability and validity) of instruments used to assess breathlessness/dyspnea rather than the potential for methodological bias within the studies using these instruments. For this, a two-step process was used; initially, the references used to support reliability and/or validity of the instrument provided by authors of studies included within this review were identified. Second a search was undertaken to identify studies of reliability and validity for each instrument identified in this review. Data were extracted for the processes used to determine reliability or validity for instrument identified in the review (for example, whether the sample included people with BMI X30 kg m À 2 , intra/inter-rater, test-rest, comparisons with physiological, respiratory-related impairment or quality of life instruments and specific statistical tests). Although a number of different types of reliability and validity exist, statistical analyses for assessing the degree of agreement between occasions of testing (reliability) or criterion data (validity) may include percentage agreement (% agreement), the degree of linear relationships (Pearson's correlation coefficients (r), Spearman's rank (r), intraclass correlation coefficients) or the likelihood that a relationship exist beyond random chance (Cohen's k). The degree of confidence with which an association can be accepted also depends upon the sample size. The guidelines proposed by Terwee et al. 17 were used to interpret the findings where acceptable reliability was supported by an ICC or weighted k (inter-rater) was at least 0.70 in a sample size of 50 participants and acceptable internal consistency was supported by an association between 0.70 and 0.95. The sensation of dyspnea is a multidimensional perceptual experience for which no gold standard criterion exists, therefore rather than criterion validity, acceptable concurrent validity was defined as an association of at least 0.70. 17 To determine which instruments could be recommended to assess the sensation of breathlessness in people with increased adiposity (Aim 2), instruments were reviewed in light of whether people with increased adiposity were represented within the development or psychometric assessment of the instruments, the strength of the psychometric properties and coverage of sensation, emotional and behavioral domains of breathlessness.
RESULTS
From the 443 citations initially obtained from the systemic search, 38 articles met the inclusion criteria. An additional 3 articles were identified through reviewing reference lists giving a total of 41 articles that were included. Figure 2 summarizes the search results.
Overview of study population, design and breathlessness context Of the 41 studies, 14 focused on participants with obesity as the primary health concern. The remaining studies explored obesity as comorbidity in a variety of respiratory disorders (for example, chronic obstructive pulmonary disease, sleep disorders and lung cancer). Of the studies included within the review 22 used experimental designs (parallel groups 15, pre/post design 5 and randomized controlled trials 2) and 19 used observational approaches (cross-sectional 14 and longitudinal 5). Details of studies can be found in Supplementary Appendix 1.
About 19 of the 41 studies provided a definition for obesity. Of these, 17 defined obesity as a BMI X30 kg m À 2 . However, Babb et al. 18 defined obesity as percentage body fat X30% (underwater weighing) whereas Park et al. 19 defined obesity as having a BMI X25 kg m À 2 . All 19 observational studies assessed breathlessness by inviting participants to recall their experience of breathlessness. The majority (18) of the 22 experimental studies induced breathlessness in participants via exercise or methacholine challenges. The remainder of the experimental studies (four) assessed whether recalled sensations of breathlessness changed following intervention (for example, weight loss drug, 20 pulmonary rehabilitation, 21 weight loss exercise protocols 22 and gastric bypass surgery 23 ), or used recalled breathlessness data to guide the selection of work rates (ramp-slope) in cardio-pulmonary exercise testing. 24 Instruments used for assessment of the sensation of breathlessness in adults with increased adiposity In the 41 studies reviewed, there were 20 instruments used to assess breathlessness. Four studies did not provide a reference for the instrument, which appeared to be developed specifically for the study. [25] [26] [27] [28] In a number of studies, different titles were provided for the same breathlessness instrument. 32, 33 ) or by a generic titles such as the dyspnea index. In this review, where breathlessness was assessed using the five statements rather than the complete symptom survey, the instrument will be referred to as the MRC (1-5) or modified MRC (mMRC; 0-4) Scale for breathlessness depending upon the grading system. In three studies, breathlessness was assessed using a subsection of a questionnaire specific to dyspnea (symptoms or behavior). Two studies used the dyspnea subsection of the Chronic Respiratory Disease Questionnaire (CRDQ) 21, 23 while Olafsdttir et al. 34 used the dyspnea questions subsection of the International Union against Tuberculosis and Lung Disease bronchial symptoms questionnaire (IUTLDQ).
Although the original questionnaire may have assessed a global construct such as respiratory-related quality of life (CRDQ) or the presence and severity of respiratory symptoms (ATS-DLD-78), by using only the subsection relevant to breathlessness/dyspnea, a different domain may have been reflected (for example, intensity, the presence or behavior). In this review, where researchers have used the subsection of a more comprehensive instrument (and Table 1 summarizes these assessment tools, including when and what the tool was originally designed for, a brief description of how the tool and which domain of sensation of breathlessness the tool measures. The most common instrument identified (16 studies) was the modified Perceived Rate of Exertion Scale (mBorg) used to assess intensity of breathlessness followed by the MRC or mMRC 9 studies and Baseline Dyspnea Index (BDI five studies), both of which assess breathlessness-related impairment. Overall, instruments that measured the intensity of breathlessness were predominantly used in experimental studies. Among the 22 experimental studies, the majority (17) used at least one instrument that measured intensity of breathlessness induced by exercise or methacholine challenge (Borg, mBorg and VAS).
Instruments that assessed functional limitation, impairment or disability because of breathlessness were generally used in observational studies to describe whether impairments related to breathlessness changed over the course of the study, or to classify participants into groups according to level of impairment (New York Heart Association (NYHA), MRC, mMRC, BDI, dyspnea score, CRDQ-D and four unreferenced categorization systems).
Domains measured by the breathlessness instruments According to Lansing's mode 10 , the sensation of breathlessness has domains of intensity, sensory quality/descriptors and unpleasantness, which lead to emotional and behavioral responses. Among the 20 tools, three explicitly measured intensity (VAS, Borg and mBorg) and two assessed sensory quality (descriptor lists based upon of Simon et al. 35 ). No tools The majority of data for reliability and validity of instruments used to assess breathlessness were derived from participants with specific chronic respiratory or cardiovascular diseases, with the exception of five studies that recruited participants with breathlessness of various causes, [39] [40] [41] [42] [43] and four studies that recruited healthy participants. 44 ; body fat (%) 15.5-39.1%; 51 six subjects with obesity; 40 ). Compounding this issue, a number of studies reporting aspects of reliability or validity of specific instruments excluded people with increased adiposity from the sample (descriptors of sensory quality (excluded BMI X26 kg m À 2 ), 45 test-retest reliability of the Borg. 46 It appears that only three instruments identified within this review have been assessed for reliability (BDI, mMRC and oxygen cost diagram (OCD)) 40 and five instruments for validity (BDI 49, 50 , mMRC 49, 50 , OCD 49, 50 , NYHA 48 and Borg 51 ) with samples that included people with increased adiposity. The metrics for the validity and reliability reported for these 16 tools are presented in Tables 2 and 3 .
Data concerning various aspects of reliability were available for the 16 assessment instruments referenced within the studies. Inter-rater agreement was not usually assessed for instruments where subjects rate their own perception of breathlessness intensity, perceived exertion, sensory quality or the presence of symptoms (OCD, VAS, Borg, descriptor lists and IUTLDQ-D). Interrater reliability for instruments that were either assessed or administered by an interviewer differed considerably with the BDI demonstrating strong consistency between raters (k w range 0.65-0.72, a ¼ 0.88, % agreement 92%) 39, 52 , whereas the NYHA demonstrated inadequate consistency between raters (k w ¼ 0.41, % agreement range 54-56%). 42, 53 For instruments that could be either interviewer administered or self-reported by subjects, inter-rater agreement varied. For example, significant differences were evident across interviewers (10-20%) 54 for the original MRC (1-5 scale) as part of the original symptoms questionnaire, 32 but consistency improved through standardized instruction/ training and by 1961, there was no significant difference between interviewers and agreement between interviewer administered and patient self-completion of the scale resulted in 88% agreement in dyspnea grades. 55 Interviewer administered versions of the mMRC (0-4) continue to have good agreement (k w ¼ 0.92, 98%). 40 Consistency between occasions of testing for the dyspnea domain of the CRDQ was 40.7 for both interviewer administered (Spearman-Brown coefficient ¼ 0.73) 56 and self-report versions (intraclass correlation coefficient ¼ 0.83, Pearson's r ¼ 0.90) 57, 58 , but there was a significant difference in scores between interviewer administered and self-reported versions reported (P ¼ 0.006, limits of agreement À 1.38 to 2.10). 57 With the exception of the OCD, consistency between occasions of testing for the majority of instruments exceeded 0.7 (BDI, 
CRDQ-D, MRC, Borg, VAS, IUTLDQ-D and descriptors)
. Data concerning test-retest of the NYHA were unable to be found. The BDI 59 , mMRC (0-4) 59 and IUTLDQ-D 60 met the criteria proposed by Terwee et al. 17 (association of X0.7 with a sample of 50 subjects) for test-retest while the BDI 52 , CRDQ-D 61 and Mmrc 52 met the criteria for internal consistency. The sensation of dyspnea is a multidimensional perceptual experience for which no gold standard criterion exists, consequently instruments assessing breathlessness are usually tested for the degree of association with physiological measures of condition severity (pulmonary function tests and functional exercise tests), alternative measures respiratory-related impairment (mMRC and BDI) or health/respiratory-related quality of life. Associations between different outcome measures may be positive or negative, as instruments can be scaled with higher (mMRC, mBorg and VAS) or lower scores (BDI, CRDQ-D and OCD) reflecting worse health outcome. Although the majority of associations reported in studies were unlikely to exist due to random chance (Po0.05), few of the associations met Terwee et al. 17 criterion for acceptable concurrent validity (40.70). They were the association between Borg and VAS scores (post 6-min walk test) 50 , BDI and shortness of breath questionnaire score 50 , BDI and mMRC 40 and mMRC and OCD. 49 Stronger significant associations (X0.5) were evident between measures of respiratory-related impairment based on functional activities (mMRC and BDI) and the severity of airways obstruction (percentage predicted forced expiratory volume in one second) 49 or functional exercise performance (6-min walk test). 39, 50, 52 Consistently high associations were evident between the BDI and mMRC 40, 50, 52 with less consistency between the mMRC or BDI and the OCD. 49, 50, 62 Associations were consistently low between CRDQ-D and other measures (pulmonary function 63 , walk test 64 , respiratory-related impairment 63 or quality of life questionnaires 61, 64, 65 ). In addition to the findings presented in Table 3 , the NYHA demonstrated predictive validity for cardiovascular mortality with hazard ratios for NYHA classes I and II vs III and IV ¼ 1.49 (95% confidence interval 1.20-1.84, Po0.0001) or 1.29 (95% confidence 48 Discriminant validity has been reported for descriptors of the sensation of breathlessness where different groups of descriptors were associated with the mechanism by which breathlessness was induced. 44, 45 Updated search. Between February 2011 and February 2012, nine papers were published that met the inclusion criteria for this review. [66] [67] [68] [69] [70] [71] [72] [73] [74] Seven breathlessness instruments were reported in these papers, of which six instruments (MRC, mMRC, Borg, VAS, BDI and NYHA) were reported in the current review. One new instrument was identified (Arrhythmia-specific QoL questionnaire Symptom checklist frequency and severity (SCL version 3). 67 In this instrument 2 out of 16 questions were specific for dyspnea over the past month (scored for frequency (0 never to 4 always) and severity (1 mild to 3 extreme)). The checklist has been reported to have good internal consistency (Cronbach a 0.87-0.92 (frequency) and 0.89-0.93 (severity), 75 however, as a stand-alone quality of life outcome measurement for patients with atrial fibrillation, the checklist has very limited published validity data. 76 No specific reliability or validity metrics could be found for the individual dyspnea items in this checklist. Within the nine studies, the most commonly used breathlessness assessment tools were m/MRC and Borg Scale (in five studies and two studies, respectively), which is in line with the findings of this review.
DISCUSSION
This review sought to describe how the sensation, rather than the mechanics, of breathlessness has been assessed in people with increased adiposity. From an evolutionary perspective, sensation drives behavior. Where the sensation or experience of breathlessness is distressing or unpleasant, behaviors that provoke or are associated with breathlessness are likely to be avoided leading to secondary health consequences (that is, reduced cardiovascular fitness, physical activity and quality of life). Accordingly, assessments of the experience of breathlessness may assess either the sensation (intensity, sensory quality or unpleasantness) or the behavioral/emotional consequences of the sensation (respiratoryrelated functional impairment, disability or quality of life).
Of the 20 instruments identified within this review, the majority assessed the impact of breathlessness upon function or quality of life dyspnea subscales. Five instruments were identified covering two of the domains of the sensation of breathlessness (intensity (VAS, Borg and mBorg)) or sensory quality (descriptors of Simon et al. 35 ). Within the studies included in this review, no instrument was identified that explicitly assessed unpleasantness of the sensation, with the remaining instrument assessing breathlessness frequency (IUTLDQ-D). There are a number of reasons why there may have been comparatively fewer instruments assessing sensation rather the impact of breathlessness on functional activities or quality of life. The neurophysiology underpinning the sensory experience of breathlessness is a relatively recent field of research and while there is a growing body of experimental work, the implications of this work are unlikely to be widespread within the clinical environment. With respect to instruments specific to the sensation of breathlessness, scales (VAS or Borg) have long been used to assess breathlessness intensity whereas similar scales for breathlessness unpleasantness are much more recent. 77, 78 There are a variety of instruments that assess the sensory quality of breathlessness (descriptors) including instruments that invite respondents to volunteer descriptors, 79 select from a series of descriptors statements, 35, 43 rate the intensity of descriptor statements 80 or rate breathlessness, intensity, unpleasantness and descriptor statements. 81 Although instruments that assess the sensory quality of breathlessness exist, to date these have generally been used to compare the experience of breathlessness between chronic conditions where dyspnea is a common feature, rather than assessment of intervention efficacy or disease progression. One further possibility is of that of 'therapeutic nihilism' 82 where individuals and their health providers are resigned to the fact that their breathlessness will increase over time as a consequence of the patients' medical condition, especially if lifestyle factors are perceived to contribute to underlying pathology (for example, smoking, excessive calorie intake and sedentary lifestyles).
Over the past 5 years, there has been an increased focus on the assessment and/or management of the sensation of breathlessness in a number of chronic conditions. In 2010 alone, there were over 20 reviews/consensus papers published concerning assessment and/or management of breathlessness in advanced cardiovascular and pulmonary disease, COPD, malignant and non-malignant disease, acute and chronic heart failure and palliative care. 83 To date, no single instrument has been advocated as a gold standard for assessment of breathlessness though recommendations have been made that dyspnea outcomes should include measures of intensity/severity, [84] [85] [86] distress, 84, 86 and impact of breathlessness on quality of life. 85, 87 Johnson et al. 85 noted that clinical trials appear to lack focus on breathlessness as a symptom, suggesting that intervention trials for relief of dyspnea prioritize assessments of the emotional and behavioral consequences of dyspnea (quality of life, physical activities and frequency of hospital admissions). In a more recent review of strategies to palliate the sensation of breathlessness, of the 34 primary studies included in the review, less than a third included a primary outcome for dyspnea; 6 of which included an outcome for breathlessness intensity, 5 for respiratory-related quality of life and 1 included a specific measure of breathlessness unpleasantness. 83 The findings of this review concur in terms of the priority given to instruments assessing the consequences of the breathlessness rather than the sensation of breathlessness as a symptom.
With this backdrop in mind, what recommendations can be made for assessing the sensation of breathlessness in people with increased adiposity? The first recommendation is that a clear distinction should be made between instruments that assess the sensation (intensity, unpleasantness and sensory quality) and the impact of sensation (respiratory-related quality of life and respiratory-related impairment).
A number of instruments are currently available for assessment of the sensation of breathlessness (intensity, unpleasantness and sensory quality) and in theory, the choice of instruments to assess the sensation of breathlessness are unlikely to differ depending upon whether participants have increased adiposity as a primary or comorbid health condition. Of those identified within this review, VAS (intensity), mBorg (perceived exertion-intensity) and descriptors of the sensation (sensory quality) 35, 43 could be recommended for use based on their clinometric properties. Among the instruments assessing breathlessness intensity both VAS and mBorg appeared to have good test re-test reliability (Table 2) , with the concurrent validity for both VAS and mBorg supported by a wider range of outcome measures (Table 3) . For assessment of sensory quality and unpleasantness, there are a number of more recently developed instruments that would be worth exploring for use in people with increased adiposity (VAS for unpleasantness, 77, 78 Dyspnea-12, 80 multidimensional dyspnea profile. 81 In contrast, selection of instruments that assess the consequences or impairments (respiratory-related impairment or quality of life) resulting from the sensation of breathlessness may need to take into account whether increased adiposity if the primary health concern or a comorbid factor of the chronic condition. In this review, researchers navigated this issue either by using a condition-specific instrument for respiratory-related impairment (for example, NYHA for people with heart failure) or including only the dyspnea subsection of condition-specific broader quality of life (for example, CRDQ chronic respiratory disease) or symptom instrument (for example, Medical Research Council Standardized Questionnaire on Respiratory Symptoms 1960, ATS-DLD-78A, WHO 1968). Among the instruments identified in this review assessing respiratory-related impairment, the BDI, CRDQ-D, MRC, mMRC and OCD all had demonstrable test re-test or inter-rater reliability with strong associations for the BDI and mMRC and measures of physiological impairment (pulmonary function, exercise capacity) and respiratory-related quality of life. However, based on clinometric properties, both the BDI and mMRC can be recommended as measure of respiratory-related impairment for participants with and without increased adiposity as a comorbid condition. One further recommendation is relevant for the MRC/ mMRC. Given the bewildering array of titles/references provided for essentially the five statements of the MRC (1-5) or mMRC (0-4), where these five statements are used rather than the broader symptom questionnaires, the term MRC Scale for breathlessness (1) (2) (3) (4) (5) or modified MRC Scale for breathlessness (0-4) would assist readers and researchers.
CONCLUSION
Assessment and management of breathlessness has increasingly become a focus in a range of chronic health conditions. This systematic search of literature published since 2005 identified 20 instruments used to assess breathlessness/dyspnea in people with increased adiposity. The majority of the tools assessed intensity and functional impairments because of breathlessness with the minority of instruments assessing sensory quality and none explicitly assessing unpleasantness of breathlessness. From the data available concerning reliability and validity of the instruments identified in this review, VAS and mBorg for breathlessness intensity, descriptors of sensation of breathlessness and BDI, mMRC could be recommended for assessing intensity, sensory quality of sensation of breathlessness and respiratory-related impairment, respectively. To date, it does not appear that in people with increased adiposity, data exist for all three domains of the sensation of breathlessness. If sensation drives behavior, comprehensive data on the sensation of breathlessness might assist in understanding the behavioral consequences of interventions.
